Tim A Smitka

Title: Innovations of Tim A Smitka

Introduction

Tim A Smitka is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of antimicrobial and antitumor compounds. With a total of three patents to his name, Smitka's work has the potential to impact medical treatments significantly.

Latest Patents

Smitka's latest patents include innovative compounds that demonstrate antimicrobial and antineoplastic activity. One of his notable patents involves antimicrobial and antitumor phenazine carboxaldehydes and derivatives. This patent describes acids, esters, imine acids, imine esters, and imine amides derived from specific phenazinecarboxylic acids. These compounds are produced by a purified strain of Streptomyces galanosa, NRRL 15738, which can generate these substances in isolable quantities from a fermentation broth. Another significant patent is for CL-1577 antibiotic compounds and their production. This patent details a purified isolate of an actinomycete identified as ATCC 39363, which produces a complex of sulfur-containing antibiotic compounds effective against transplanted tumors. The process involves cultivating the isolate under aerobic conditions in a suitable culture medium.

Career Highlights

Tim A Smitka is currently associated with Warner-Lambert Company, where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential applications in treating various medical conditions.

Collaborations

Smitka has collaborated with notable colleagues, including James C French and Richard H Bunge, contributing to the advancement of his research and innovations.

Conclusion

Tim A Smitka's contributions to the field of antimicrobial and antitumor compounds highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing science and technology in healthcare.